HIGH BASELINE SERUM IL-6 IDENTIFIES A SUBGROUP OF RHEUMATOID ARTHRITIS PATIENTS WITH RAPID JOINT DAMAGE AND CLINICAL PROGRESSION AND PREDICTS INCREASED SARILUMAB TREATMENT RESPONSE
Rheumatology(2019)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
Rheumatology(2019)